Gastroenterology
Volume 128, Issue 1 , Pages 33-42, January 2005

Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection

  • Aileen Marshall

      Affiliations

    • Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, England
  • ,
  • Simon Rushbrook

      Affiliations

    • Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, England
  • ,
  • Susan E. Davies

      Affiliations

    • Department of Pathology, Addenbrooke’s Hospital, University of Cambridge, Cambridge, England
  • ,
  • Lesley S. Morris

      Affiliations

    • MRC Cancer Cell Unit, Hutchison/MRC Research Centre, Cambridge, England
  • ,
  • Ian S. Scott

      Affiliations

    • MRC Cancer Cell Unit, Hutchison/MRC Research Centre, Cambridge, England
  • ,
  • Sarah L. Vowler

      Affiliations

    • Centre for Applied Medical Statistics, Department of Public Health and Primary Care, University Forvie Site, Cambridge, England
  • ,
  • Nicholas Coleman

      Affiliations

    • MRC Cancer Cell Unit, Hutchison/MRC Research Centre, Cambridge, England
  • ,
  • Graeme Alexander

      Affiliations

    • Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Cambridge, England
    • Corresponding Author InformationAddress requests for reprints to: Graeme Alexander, MD, Department of Medicine, Addenbrooke’s Hospital, University of Cambridge, Box 157, Hills Road, Cambridge CB2 2QQ England.fax: (44) 1223-216111.

Received 6 April 2004; accepted 16 September 2004.

Backgrounds & Aims: An increased risk of hepatitis C virus (HCV)-related cirrhosis is associated with hepatic steatosis, older age, and high alcohol consumption, which could be explained by synergistic effects on cell proliferation. We aimed to investigate hepatocyte cell cycle state and phase distribution in chronic HCV infection. Methods: Liver biopsy specimens diagnostic for chronic HCV (70), liver regeneration following transplant-related ischemic-reperfusion injury (15), and “normal” liver adjacent to colorectal cancer metastasis (10) were studied. Immunohistochemistry was used to detect cell cycle phase markers cyclin D1 (maximal in G1), cyclin A (S), cyclin B1 (cytoplasmic during G2) and phosphorylated histone 3 protein (mitosis), mini-chromosome maintenance protein 2 (Mcm-2; present throughout the cell cycle), and cyclin-dependent kinase inhibitor p21, which inhibits G1/S progression. Results: Hepatocyte Mcm-2 expression was elevated in chronic HCV and liver regeneration (13% vs 26.4%) but negligible in “normal” liver. In proportion to Mcm-2, there was no difference in cyclin D1 between chronic HCV infection and liver regeneration (51.6% of Mcm-2-positive hepatocytes vs 52.6%). In contrast, there was a striking reduction in cyclin A (3% vs 16.3%), cyclin B1 (.4% vs 2.3%), and phosphorylated histone 3 protein (0% vs 3.8%) in chronic HCV infection compared with liver regeneration. In chronic HCV infection, Mcm-2 and p21 expression were associated with fibrosis stage and positive serum HCV RNA. Conclusions: The data are consistent with hepatocyte G1 arrest in chronic HCV infection. This could impair hepatocellular function and limit hepatic regeneration.

Abbreviations used in this paper:  cdk, cyclin-dependent kinase , LI, labeling index , Mcm-2, mini-chromosome maintenance protein 2 , PH3, phosphorylated histone 3 protein

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A.M. is supported by the National Blood Service and the Raymond & Beverley Sackler fund, and N.C. is supported by the Medical Research Council and Cancer Research UK.

PII: S0016-5085(04)01745-7

doi:10.1053/j.gastro.2004.09.076

Gastroenterology
Volume 128, Issue 1 , Pages 33-42, January 2005